REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD
RNS Number : 3578MSociete Generale SA07 January 2019FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
04/01/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,710,893
0.22
16,706,039
2.13
(2) Cash-settled derivatives:
16,189,760
2.06
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
0
0.00
125,000
0.02
TOTAL:
17,900,653
2.28
16,831,039
2.15
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit JPY
Ordinary
Purchase
1,500
3715
Ordinary
Purchase
1,200
3715
Ordinary
Purchase
100
3712.5
Ordinary
Purchase
600
3680.5
Ordinary
Purchase
500
3693.5
Ordinary
Purchase
600
3709
Ordinary
Purchase
600
3691.5
Ordinary
Purchase
100
3692
Ordinary
Purchase
300
3722
Ordinary
Purchase
300
3724
Ordinary
Purchase
300
3723
Ordinary
Purchase
800
3603
Ordinary
Purchase
300
3760
Ordinary
Purchase
400
3695
Ordinary
Purchase
300
3760
Ordinary
Purchase
300
3759
Ordinary
Purchase
300
3755
Ordinary
Purchase
500
3687
Ordinary
Purchase
300
3675
Ordinary
Purchase
300
3676
Ordinary
Purchase
300
3675
Ordinary
Purchase
500
3667
Ordinary
Purchase
500
3701
Ordinary
Purchase
200
3617
Ordinary
Purchase
2,500
3604
Ordinary
Purchase
100
3607
Ordinary
Purchase
1,500
3620
Ordinary
Purchase
400
3608
Ordinary
Purchase
100
3608
Ordinary
Purchase
200
3608
Ordinary
Purchase
200
3610
Ordinary
Purchase
1,500
3620
Ordinary
Purchase
100
3611
Ordinary
Purchase
100
3613
Ordinary
Purchase
100
3612
Ordinary
Purchase
600
3617
Ordinary
Purchase
1,000
3618
Ordinary
Purchase
300
3619
Ordinary
Purchase
1,500
3620
Ordinary
Purchase
600
3617
Ordinary
Purchase
1,100
3617
Ordinary
Purchase
100
3616
Ordinary
Purchase
1,500
3620
Ordinary
Purchase
1,500
3624
Ordinary
Purchase
1,500
3627
Ordinary
Purchase
300
3627
Ordinary
Purchase
3,000
3625
Ordinary
Purchase
100
3628
Ordinary
Purchase
100
3628
Ordinary
Purchase
500
3629
Ordinary
Purchase
1,500
3627
Ordinary
Purchase
1,500
3631
Ordinary
Purchase
1,500
3631
Ordinary
Purchase
200
3635
Ordinary
Purchase
100
3635
Ordinary
Purchase
500
3632
Ordinary
Purchase
1,300
3637
Ordinary
Purchase
1,100
3638
Ordinary
Purchase
1,500
3640
Ordinary
Purchase
300
3644
Ordinary
Purchase
1,500
3643
Ordinary
Purchase
1,500
3644
Ordinary
Purchase
1,500
3644
Ordinary
Purchase
1,500
3644
Ordinary
Purchase
1,000
3634
Ordinary
Purchase
200
3645
Ordinary
Purchase
1,000
3646
Ordinary
Purchase
500
3635
Ordinary
Purchase
1,500
3636
Ordinary
Purchase
1,400
3637
Ordinary
Purchase
1,500
3642
Ordinary
Purchase
1,500
3641
Ordinary
Purchase
300
3640
Ordinary
Purchase
500
3634
Ordinary
Purchase
700
3641
Ordinary
Purchase
300
3734
Ordinary
Purchase
300
3689
Ordinary
Purchase
600
3684
Ordinary
Purchase
200
3623
Ordinary
Purchase
300
3701
Ordinary
Purchase
300
3644
Ordinary
Purchase
300
3678
Ordinary
Purchase
300
3739
Ordinary
Purchase
200
3657
Ordinary
Purchase
1,600
3722
Ordinary
Purchase
1,100
3761
Ordinary
Purchase
900
3760
Ordinary
Purchase
100
3757
Ordinary
Purchase
100
3752
Ordinary
Purchase
500
3725
Ordinary
Purchase
800
3671
Ordinary
Purchase
1,100
3685
Ordinary
Purchase
700
3667
Ordinary
Purchase
200
3669
Ordinary
Purchase
200
3670
Ordinary
Purchase
100
3729
Ordinary
Purchase
100
3695
Ordinary
Purchase
800
3696
Ordinary
Purchase
200
3738
Ordinary
Purchase
200
3691
Ordinary
Purchase
600
3672
Ordinary
Purchase
600
3759
Ordinary
Purchase
1,100
3726
Ordinary
Purchase
1,100
3702
Ordinary
Purchase
1,100
3696
Ordinary
Purchase
1,100
3698
Ordinary
Purchase
500
3701
Ordinary
Purchase
1,100
3677
Ordinary
Purchase
1,100
3680
Ordinary
Purchase
200
3697
Ordinary
Purchase
500
3675
Ordinary
Purchase
1,100
3632
Ordinary
Purchase
200
3750
Ordinary
Purchase
1,100
3635
Ordinary
Purchase
1,100
3641
Ordinary
Purchase
1,100
3639
Ordinary
Purchase
300
3637
Ordinary
Purchase
100
3747
Ordinary
Purchase
1,100
3642
Ordinary
Purchase
200
3642
Ordinary
Purchase
100
3643
Ordinary
Purchase
1,100
3645
Ordinary
Purchase
200
3644
Ordinary
Purchase
1,100
3710
Ordinary
Purchase
1,100
3648
Ordinary
Purchase
1,100
3649
Ordinary
Purchase
1,100
3650
Ordinary
Purchase
1,100
3660
Ordinary
Purchase
1,000
3660
Ordinary
Purchase
900
3675
Ordinary
Purchase
1,100
3656
Ordinary
Purchase
200
3653
Ordinary
Purchase
1,100
3655
Ordinary
Purchase
700
3742
Ordinary
Purchase
1,700
3740
Ordinary
Purchase
500
3671
Ordinary
Purchase
25,400
3706.880165
Ordinary
Purchase
32
3705
Ordinary
Purchase
16,400
3620
Ordinary
Purchase
1,000
3620
Ordinary
Purchase
10,700
3620
Ordinary
Purchase
2,000
3620
Ordinary
Purchase
2,700
3620
Ordinary
Sale
1,800
3620.5
Ordinary
Sale
200
3622.5
Ordinary
Sale
4,300
3623
Ordinary
Sale
1,200
3621.5
Ordinary
Sale
1,500
3624.5
Ordinary
Sale
1,500
3626
Ordinary
Sale
1,500
3626.5
Ordinary
Sale
1,100
3627.5
Ordinary
Sale
1,500
3630
Ordinary
Sale
700
3634
Ordinary
Sale
600
3632
Ordinary
Sale
200
3638.5
Ordinary
Sale
100
3638.5
Ordinary
Sale
300
3643
Ordinary
Sale
300
3643
Ordinary
Sale
1,500
3635
Ordinary
Sale
1,100
3641.5
Ordinary
Sale
1,500
3637.5
Ordinary
Sale
1,200
3632
Ordinary
Sale
600
3642
Ordinary
Sale
11,600
3715
Ordinary
Sale
1,100
3742
Ordinary
Sale
100
3635
Ordinary
Sale
100
3635
Ordinary
Sale
600
3632.5
Ordinary
Sale
1,100
3635
Ordinary
Sale
800
3674
Ordinary
Sale
100
3761
Ordinary
Sale
100
3748
Ordinary
Sale
2,500
3715
Ordinary
Sale
500
3712
Ordinary
Sale
400
3730
Ordinary
Sale
100
3730
Ordinary
Sale
100
3730
Ordinary
Sale
400
3730
Ordinary
Sale
500
3741
Ordinary
Sale
400
3700
Ordinary
Sale
500
3710
Ordinary
Sale
500
3711
Ordinary
Sale
500
3711
Ordinary
Sale
500
3698
Ordinary
Sale
400
3747
Ordinary
Sale
6,100
3715
Ordinary
Sale
100
3684
Ordinary
Sale
100
3680
Ordinary
Sale
100
3694
Ordinary
Sale
100
3690
Ordinary
Sale
100
3691
Ordinary
Sale
100
3698
Ordinary
Sale
100
3713
Ordinary
Sale
100
3696
Ordinary
Sale
1,000
3625
Ordinary
Sale
500
3624
Ordinary
Sale
100
3633
Ordinary
Sale
100
3640
Ordinary
Sale
600
3643
Ordinary
Sale
100
3716
Ordinary
Sale
100
3646
Ordinary
Sale
500
3640
Ordinary
Sale
1,500
3635
Ordinary
Sale
100
3718
Ordinary
Sale
100
3677
Ordinary
Sale
1,200
3715
Ordinary
Sale
300
3684
Ordinary
Sale
300
3699
Ordinary
Sale
300
3688
Ordinary
Sale
300
3685
Ordinary
Sale
300
3703
Ordinary
Sale
100
3606
Ordinary
Sale
200
3605
Ordinary
Sale
400
3607
Ordinary
Sale
300
3609
Ordinary
Sale
100
3610
Ordinary
Sale
300
3619
Ordinary
Sale
300
3618
Ordinary
Sale
100
3615
Ordinary
Sale
300
3625
Ordinary
Sale
500
3619
Ordinary
Sale
600
3624
Ordinary
Sale
600
3631
Ordinary
Sale
100
3698
Ordinary
Sale
300
3634
Ordinary
Sale
300
3700
Ordinary
Sale
300
3698
Ordinary
Sale
600
3675
Ordinary
Sale
300
3715
Ordinary
Sale
100
3700
Ordinary
Sale
300
3710
Ordinary
Sale
700
3722
Ordinary
Sale
1,000
3722
Ordinary
Sale
1,100
3709
Ordinary
Sale
400
3716
Ordinary
Sale
500
3706
Ordinary
Sale
1,000
3685
Ordinary
Sale
100
3711
Ordinary
Sale
1,100
3691
Ordinary
Sale
500
3679
Ordinary
Sale
1,100
3685
Ordinary
Sale
700
3670
Ordinary
Sale
1,100
3766
Ordinary
Sale
1,100
3694
Ordinary
Sale
600
3753
Ordinary
Sale
1,000
3691
Ordinary
Sale
300
3689
Ordinary
Sale
1,100
3690
Ordinary
Sale
1,100
3682
Ordinary
Sale
400
3704
Ordinary
Sale
800
3752
Ordinary
Sale
2,200
3707
Ordinary
Sale
900
3672
Ordinary
Sale
600
3700
Ordinary
Sale
1,100
3700
Ordinary
Sale
1,100
3747
Ordinary
Sale
1,100
3678
Ordinary
Sale
300
3703
Ordinary
Sale
200
3634
Ordinary
Sale
100
3634
Ordinary
Sale
100
3633
Ordinary
Sale
100
3633
Ordinary
Sale
100
3632
Ordinary
Sale
100
3632
Ordinary
Sale
100
3631
Ordinary
Sale
1,100
3631
Ordinary
Sale
300
3634
Ordinary
Sale
1,100
3639
Ordinary
Sale
1,000
3638
Ordinary
Sale
600
3643
Ordinary
Sale
800
3641
Ordinary
Sale
700
3696
Ordinary
Sale
800
3642
Ordinary
Sale
1,100
3642
Ordinary
Sale
800
3644
Ordinary
Sale
300
3642
Ordinary
Sale
1,100
3693
Ordinary
Sale
900
3645
Ordinary
Sale
1,100
3646
Ordinary
Sale
1,000
3640
Ordinary
Sale
600
3645
Ordinary
Sale
200
3638
Ordinary
Sale
1,100
3640
Ordinary
Sale
1,100
3648
Ordinary
Sale
1,100
3647
Ordinary
Sale
300
3648
Ordinary
Sale
1,100
3647
Ordinary
Sale
800
3659
Ordinary
Sale
100
3658
Ordinary
Sale
600
3726
Ordinary
Sale
1,600
3664
Ordinary
Sale
1,100
3676
Ordinary
Sale
200
3673
Ordinary
Sale
200
3675
Ordinary
Sale
500
3672
Ordinary
Sale
300
3668
Ordinary
Sale
800
3669
Ordinary
Sale
100
3673
Ordinary
Sale
700
3673
Ordinary
Sale
1,100
3656
Ordinary
Sale
1,100
3685
Ordinary
Sale
1,100
3757
Ordinary
Sale
1,100
3694
Ordinary
Sale
300
3662
Ordinary
Sale
500
3672
Ordinary
Sale
992
3957.3
Ordinary
Sale
32
3705
Ordinary
Sale
16,400
3620
Ordinary
Sale
32
3683
Ordinary
Sale
16,400
3620
Total Purchases
156,332
Total Sales
154,056
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
07/01/2019
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
Listed call-option
Sale
125,000
5,500
European options
13/06/2019
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETUGUPWGUPBUBM
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement